[1] 阴建,邱思睿,张凯. 血清CEA、CA19-9和CA72-4检测在胃癌机会性筛查中应用价值的荟萃分析[J]. 中华健康管理学杂志,2024,18(4): 271-278. [2] 张海云,蔡晓波,郭宝明,等. 胃癌患者Hp感染与CyclinD1、NF-kb、Beclin1表达及临床病理特征的关系分析[J]. 中国实验诊断学,2020,24(5): 773-776. [3] 王晓娜,赵永捷,张自立,等. 老年患者腹腔镜胃癌根治术后发生并发症影响因素分析的多中心研究[J]. 中华消化外科杂志,2024,23(3): 386-391. [4] Lin JX, Wang ZK, Huang YQ, et al.Dynamic Changes in Pre- and Postoperative Levels of Inflammatory Markers and Their Effects on the Prognosis of Patients with Gastric Cancer[J]. J Gastrointest Surg, 2021, 25(2): 387-396. [5] Zhang H, Pan YZ, Cheung M, et al.LAMβ3 mediates apoptotic, proliferative, invasive, and metastatic behaviors in pancreatic cancer by regulating the PI3K/Akt signaling pathway[J]. Cell Death Dis, 2019, 10(3): 230. [6] 张灿灿,谭志军. FMNL2在胃癌组织中的表达及其临床意义[J]. 天津医科大学学报,2020,26(2): 149-152. [7] 邾孟祥. 胃癌患者血清中CPXM1的表达及其与miR-3127-3p的相关性[D]. 芜湖:皖南医学院,2023. [8] Wang FH, Shen L, Li J, et al.The Chinese Society of Clinical Oncology (CSCO): clinical guidelines for the diagnosis and treatment of gastric cancer[J]. Cancer Commun (Lond), 2019, 39(1): 10. [9] Zaanan A, Bouché O, Benhaim L, et al.Gastric cancer: French intergroup clinical practice guidelines for diagnosis, treatments and follow-up (SNFGE, FFCD, GERCOR, UNICANCER, SFCD, SFED, SFRO)[J]. Dig Liver Dis, 2018, 50(8): 768-779. [10] Gu Q, Mi L, Lai C, et al.CPXM1 correlates to poor prognosis and immune cell infiltration in gastric cancer[J]. Heliyon, 2023, 10(3): e21909. [11] Chen Y, Li ZY, Zhou GQ, et al.An Immune-Related Gene Prognostic Index for Head and Neck Squamous Cell Carcinoma[J]. Clin Cancer Res, 2021, 27(1): 330-341. [12] 胡颖,赵丽,尤琦,等. CPXM1 mRNA在胃癌组织中的表达及其与临床病理特征关系的研究[J]. 哈尔滨医科大学学报,2023,57(3): 275-279. [13] 张东鹏,潘正波,宋昕. LAMβ3、SPOCK1、PRR11在膀胱癌组织中的表达及相关性[J]. 广东医学,2021,42(11): 1347-1351. [14] 蒙春梅,任玲,唐茂林,等. S1P/S1PR1通路调节LAMβ3的表达对食管鳞癌细胞迁移、黏附和转移的影响[J]. 中国细胞生物学学报,2022,44(8): 1579-1591. [15] 张泽天,杨婕琳,吴娜,等. 胃癌组织RRBP1、LAMβ3的mRNA表达水平及其与患者临床病理特征、预后的关系[J]. 广西医学,2023,45(21): 2561-2565. [16] 朱曦龄,黎功. FMNL2基因对大肠癌细胞SW620增殖、侵袭及转移的影响[J]. 山东医药,2017,57(24): 34-37. [17] 钱粒,陆舒旻,何鑫,等. PRDX1、HMGA2、FMNL2在胃癌组织中的表达及与临床病理特征、上皮间充质转化和预后的关系研究[J]. 现代生物医学进展,2022,22(17): 3367-3372. |